BNIP3 and breast carcinoma: In the current study, we have developed a measles virus armed with BNiP3, pro-apoptotic gene of human origin (rMV-BNiP3) as a therapeutic agent for treatment of breast carcinoma both as a monotherapy and a component of combination therapy based on chemotherapy.